This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Dartmouth-Hitchcock Medical Center: Spine Care
Huckman, Robert S.; Porter, Michael E.; Gordon, Rachel; Kindred, NatalieCase HBS-609016-EStrategyDescribes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in physical medicine and pain management, mental health providers, and occupational and physical therapists. The Center was created to address what its founder, James Weinstein, M.D., s...Starting at €8.20
-
Deworming Kenya: Translating Research into Action (A)
Ashraf, Nava; Shah, Neil Buddy; Gordon, RachelCase HBS-910001-EKaren Levy and her colleague, Margaret Ndanyi, have spent the last six months planning and preparing for a national Kenyan program to target school children most at risk for parasitic worm infection. One week after its launch, the program seemed to be going well but Ndanyi and Levy knew that it still needed to be administered in almost 40 districts at thousands of schools. They wondered: Would they meet their goal of deworming over three million ...Starting at €8.20
-
Whose Money Is It Anyway (C)
Narayanan, V.G.; Hamermesh, Richard G.; Gordon, RachelCase HBS-810031-EAccounting and ControlThe case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used.Starting at €5.74
-
Whose Money Is It Anyway (A)
Narayanan, V.G.; Hamermesh, Richard G.; Gordon, RachelCase HBS-810008-EAccounting and ControlThe Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must negotiate who has control of the funds which impacts how the funds may be used.Starting at €8.20
-
Offering the Right Service in the Right Place: Growing Orthopedics at the Brigham and Women's/Faulkner (BW/F) Hospitals
Narayanan, V.G.; Wilson, Michael G; Gordon, RachelCase HBS-108016-EAccounting and ControlTo maximize their effectiveness, color cases should be printed in color. After the merger of two local hospitals, hospital leaders much decide how to reorganize services to take advantage of newly created efficiencies. Focuses on the Orthopedics department at one of the hospitals.Starting at €8.20
-
Differences at Work: Jason (A)
Sucher, Sandra J.; Gordon, RachelCase HBS-408016-ELeadership and People ManagementIn Differences at Work: Jason (A) HBS Case No. 9-408-016 Jason is a member of his firm's recruiting team, which has a mandate to create a more diverse workforce. When the group decides to interview a candidate based on the candidate's race, Jason wonders whether they made the right decision and how, in general, diversity goals should be achieved.Starting at €8.20
-
Differences at Work: Sameer (A)
Sucher, Sandra J.; Gordon, RachelCase HBS-609053-EService and Operations ManagementIn Differences at Work: Sameer (A) HBS Case No. 9-609-053 Sameer, an Indian Muslim, is a summer intern in a small, predominantly Jewish firm. Prompted by a conflict in the Middle East, members of the organization make a number of anti-Muslim jokes. Sameer wonders whether he should surface his discomfort; he otherwise enjoys the firm, and is hoping to be given a full-time job offer following his internship.Starting at €8.20
-
Plavix: Drugs in the Age of Personalized Medicine
Hamermesh, Richard G.; Aspinall, Mara G.; Gordon, RachelCase HBS-811001-EEntrepreneurshipPIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon and recently new data had been discovered which indicated that a small subset of the population would be at risk for stroke, heart attack or even death if they took PIavix. As a result the FDA had added a black box warning-the agency's most severe--to Plavix's label in 2010. In addition, it had been discovered that the common...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
The Broad Institute: Applying the Power of Genomics to Medicine
Sato, Vicki L.; Gordon, RachelCase HBS-608114-EIn June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just four years the Broad had made many important scientific contributions to the bio-medical field. These included understanding genetic alterations in cancer; building an RNAi Consortiu...Starting at €8.20